Breaking News

PCI Synthesis Adds Advanced Polymer Mfg. Group

New capability expands customer base and reach within this market

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

PCI Synthesis, Inc., a drug substance manufacturer of new chemical entities (NCEs) and generic active pharmaceutical ingredients (APIs), has formed a cGMP Advanced Polymer Development and Manufacturing Group, which is currently working on more than 12 advanced polymer-based projects. The addition of an advanced polymer-based materials development and manufacturing capability expands the company’s customer base and reach within this growing market.   The team includes several Ph.D.-level polyme...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters